Summary
Migraine and inflammation are correlated. This Iranian study aimed to assess the effect of coenzyme Q10 supplementation, an anti-inflammatory agent, on inflammation and clinical features of migraine. 45 women aged 18 to 50 years and diagnosed with migraine participated in this trial. 23 patients received 400 mg/day coenzyme Q10, and 22 patients received a placebo for three months. Several parameters were measured at the beginning and end of the study. Coenzyme Q10 supplementation induced an increased coenzyme Q10 level, and it significantly reduced an inflammation parameter and important correlated parameters for migraine attacks. Additionally, coenzyme Q10 supplementation caused a significant improvement in frequency, severity, and duration of migraine attacks compared to the placebo, indicating that coenzyme Q10 may have favorable effects in migraine patients. You can find more details in the study.
References
Dahri et al.